EAU 2017 - Renal Cancer

Viewing 1-9 of 9 articles

EAU 2017: Parenchyma volume and renal function after different types of nephron-sparing minimally invasive surgery in patients with renal cell carcinoma

EAU 2017: Lymph node dissection is not associated with increased 30-day complication among patients undergoing radical nephrectomy for renal cell carcinoma: a propensity-score based analysis

EAU 2017: Should partial nephrectomy be considered an imperative indication in stage II chronic kidney disease?

EAU 2017: State-of-the-art Lecture Immunotherapy: Open Questions and Trials

State-of-the-art Lecture Immunotherapy: Impact from Surgeon’s Point of View

EAU 2017: State-of-the-art Lecture Immunotherapy: Impact from Oncologist’s Point of View

EAU 2017: Debate on Kidney Cancer – partial nephrectomy is better done with the robot - Con

EAU 2017: A national, prospective, non-interventional study (NIS) of nivolumab (BMS-936558) in patients with advanced renal cell carcinoma after prior therapy

EAU 2017: The role of surgery in metastatic renal cancer

email news signup